Skip to main content
SpringerLink
Log in

Checkpointhemmung beim Merkelzellkarzinom

Keine abskopalen Effekte bei Immuntherapie plus stereotaktischer Radiotherapie

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Kim S et al. Lancet. 2022;400(10357):1008-19

  2. D'Angelo SP et al. JAMA Oncol. 2018;4(9):e180077

  3. Ngwa W et al. Nat Rev Cancer. 2018;18(5):313-22

  4. Sun R et al. J Immunother Cancer. 2020;8(2):e001429

  5. Clump DA et al. ASCO. 2022;Abstr 6007

  6. Vanpouille-Box C et al. Nat Commun. 2017;8:15618

  7. Rückert M et al. Cancers (Basel). 2021;13(4):714

  8. Brooks ED, Chang JY. Nat Rev Clin Oncol. 2019;16(2):123-35

  9. Schubert P et al. Front Oncol. 2020;10:576643

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum des Saarlandes, Kirrberger Straße. Gebäude 6.5, 66421, Homburg, Deutschland

    Sören Schnellhardt &  Markus Hecht

  2. Strahlenklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054, Erlangen, Deutschland

    Udo S. Gaipl

Authors
  1. Sören Schnellhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Hecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Udo S. Gaipl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schnellhardt, S., Hecht, M. & S. Gaipl, U. Keine abskopalen Effekte bei Immuntherapie plus stereotaktischer Radiotherapie. InFo Hämatol Onkol 26, 31–33 (2023). https://doi.org/10.1007/s15004-023-0007-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-023-0007-x

Search

Navigation